insights_auto
Why is YP2 down ६.०२%?
Dive Deeperchevron_right
YP2:FRA
BioLine RX Ltd - ADR
€ १.५६
arrow_downward
-६.०२%(-०.१०) 1D
अक्टोबर ३०, २२:००:०० GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YP2...
Open
€ १.५६
High
€ १.५६
Low
€ १.५६
Mkt. cap
९५.९७ लाख
Avg. vol.
२५.००
Volume
०.००
52-wk high
€ ३.२६
52-wk low
€ १.५१
No. of employees
२२
Open
€ १.५६
High
€ १.५६
Low
€ १.५६
Mkt. cap
९५.९७ लाख
Avg. vol.
२५.००
Volume
०.००
52-wk high
€ ३.२६
52-wk low
€ १.५१
No. of employees
२२
News stories
From web sources and news partners
The Chronicle-Journal
·
१३ मिनेट पहिले
Napco earnings: what to look for from NSSC
UA.NEWS
·
५ मिनेट पहिले
SK hynix suspends plans to list Solidigm on Nasdaq — Korea Herald
www.tokenpost.com
·
१ घण्टा पहिले
BiFu Opens Anthropic Pre-IPO Trading Ahead of Planned Nasdaq Listing
Yahoo Finance
·
१३ घण्टा पहिले
Tom Lee Thinks One Investor Might Be Behind Nasdaq’s Stock Crash
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR